Work

Supplementary Figure S1 from Agreement between Surveillance, Epidemiology, and End Results– and Medicare Claims–Derived Uterine Cancer Treatment Data

Year: 2026

Type: supplementary-materials

Abstract: Yearly prevalence of A.) hysterectomy with or without BSO, B.) hysterectomy with BSO, C.) lymphadenectomy, D.) EBRT, E.) VBT, and F.) Chemotherapy by data source

DOI: 10.1158/1055-9965.31910885

Authors: Ashley S. Felix, Jiahao Ping, Caitlin E. Meade, Simran A. Kanal, Qinhan Hu, Tasleem J. Padamsee, Macarius M. Donneyong, Allison M. Quick, Anusha M. Vable, Kemi M. Doll, Jennifer A. Sinnott

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7147198446

Cites:

Cited by:

Related to: 10